Navigation Links
Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy

ur technology to prove safe or effective; our inability to obtain regulatory approval for our technology, which is only in the clinical development stage; delay or failure to complete clinical studies; our dependence on our license agreement with Aruba International B.V.; our reliance on collaborations with strategic partners and consultants; competition in our industry, including the development of new products by others that may provide alternative or better therapies; failure to secure and enforce our intellectual property rights; risks associated with use of biological and hazardous materials; acceptance of our potential products by healthcare providers and patients; our exposure to product liability claims; and our dependence on key personnel.

This release should be read in conjunction with the consolidated financial statements and notes thereto included in our most recent reports on Form 10-K and Form 10-Q. Copies are available through the SEC's Electronic Data Gathering Analysis and Retrieval system (EDGAR) at www.sec.gov. Lipid Sciences assumes no obligation to update the forward-looking statements included in this document.

Press releases for Lipid Sciences, Inc. are available on our website: www.lipidsciences.com. If you would like to receive our press releases via email, please contact: info@lipidsciences.com.

FOR FURTHER INFORMATION CONTACT:
Deborah S. Lorenz
Vice President, Investor Relations and
Corporate Communications
Lipid Sciences, Inc.
925-249-4031
Contact via http://www.marketwire.com/mw/emailprcntct?id=4D79E4FEB6C8C350

SOURCE: Lipid Sciences, Inc.


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Inspire Announces Presentations at Two European Scientific Conferences
6. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
7. IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
8. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
9. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
10. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
11. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
Post Your Comments:
(Date:5/29/2015)... 28, 2015 Research and Markets ( http://www.researchandmarkets.com/research/p37spr/north_america ... America Open System MRI Market - Growth, Trends And ... The key players in the industry are ... Healthcare and Toshiba Medical Systems ... CT because of its higher sensitivity and use of ...
(Date:5/29/2015)... Massachusetts and SPARTANBURG, South Carolina ... The Guardian Research Network and Molecular Health have announced ... and molecular diagnostic decision support to the majority of ... Guardian Research Network will collaborate with Molecular Health to ... testing to identify cohorts from hundreds of thousands of ...
(Date:5/29/2015)... , May 29, 2015  Haemonetics Corporation (NYSE: ... , Chief Operating Officer, will present at the JMP ... on June 23 rd , 2015 at ... access Mr. Davies, presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
Breaking Medicine Technology:North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
(Date:5/30/2015)... 30, 2015 On Thursday, May ... Charles Simone and Dr. Evan Alley both of ... the Mesothelioma Experts’ series. The interview was part ... centers of excellence. Drs. Simone and Alley were ... Hesdorffer, with whom they discussed the mesothelioma program ...
(Date:5/30/2015)... May 30, 2015 Nicole Blodgett, ... Disability Income Associate (DIA) designation to further her ... designation is designed for insurance advisors, health care ... their knowledge and expertise associated with the risk ... DIA designation is only the latest accomplishment in ...
(Date:5/30/2015)... May 30, 2015 San Luis ... she is offering a free analysis and consultation for ... coincides with Disability Awareness Month, which was created by ... across the United States such as Polk recognize the ... awareness about the possibility of disability, as well as ...
(Date:5/30/2015)... 30, 2015 A live auction will ... equipment from hospitals, surgery centers and other medical facilities ... be sold including radiology, surgery, endoscopy, lab, anesthesia, exam ... take place Tuesday, June 2nd starting at 10:00am EDT. ... at 5025 North Hiatus Rd., Sunrise, FL 33351. ...
(Date:5/29/2015)... MO (PRWEB) May 29, 2015 Based in ... autism awareness shirts for a couple of months ... Their latest release, which reads “I’m not misbehaving, I ... worn by the parent’s of an autistic child in order ... of autism. , Not only are they raising awareness through ...
Breaking Medicine News(10 mins):Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2
... to a recent study researchers find people who get only four ... in turn could lead to weight gain. ,An investigation ... appetites were measured before the study started, after they had slept ... had slept about 10 hours a night for two nights. Levels ...
... transplantation procedure that will most likely help patients with ... been implemented by a team of Chennai doctors.// ... and Plasmapheresis,' enables patients with renal failure to accept ... "Through this technique we temporarily blind the function of ...
... recent study researchers estimated the likely extent of the cancer ... in // various developed countries. ,Investigators report the ... percent to over 3 percent in Japan. Japan has the ... the United Kingdom, researchers say the risk of cancer was ...
... as many as 14 percent of pregnant women suffer ... use antidepressants during pregnancy. Studies involving infants exposed to ... ill effects, so most doctors believe these drugs can ... have only compared major outcomes, such as physical growth ...
... chronic chest pain sufferers exercise longer. When the drug ranolazine ... to improve the total exercise time of patients with symptoms ... review by the FDA. For this study, more than 800 ... a placebo or one or two doses of ranolazine. Patients ...
... arthritis is a chronic inflammatory disease of the immune ... researchers say // people consuming high amounts of red ... . ,Researchers compared 88 rheumatoid arthritis patients, ... and women between the ages of 45 and 70, ...
Cached Medicine News:
... Revision System offers a femoral option and ... cam action that engages at 60 degrees ... femoral roll-back motion and allow for 130 ... in conjunction with the femur is designed ...
... system was designed to replicate normal ... has a recessed, deepened and extended ... the patella, which has been shown ... groove promotes more normal kinematics and ...
... The Biopro TKO implant ... conservative knee implants available. The ... posterior cruciate ligaments. The implant ... for patients while preserving bone ...
... Knee System's curved-on-curved articulation maintains full inter-changeability. ... for better patient fit. The Maxim ... knee's proven concepts with expanded options to ... Maxim is indicated for use in total ...
Medicine Products: